09:45-10:10OPT-BIRISK trial: interpretation of extended antiplatelet therapy with clopidogrel alone versus dual antiplatelet therapy (DAPT) in high-risk patients
Speaker:
Yi Li
10:10-10:20Discussion
10:20-10:45Interpretation of the 3-year clinical results of PADN-5 Trial